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Abstract. 
 
Ubiquitin-conjugating enzymes (UBC) cata-
lyze the covalent attachment of ubiquitin to target pro-
teins and are distinguished by the presence of a UBC 
domain required for catalysis. Previously identified 
members of this enzyme family are small proteins and 
function primarily in selective proteolysis pathways. 
Here we describe BRUCE (BIR repeat containing 
ubiquitin-conjugating enzyme), a giant (528-kD) ubiq-
uitin-conjugating enzyme from mice. BRUCE is mem-
brane associated and localizes to the Golgi compart-
ment and the vesicular system. Remarkably, in addition 
to being an active ubiquitin-conjugating enzyme, 
BRUCE bears a baculovirus inhibitor of apoptosis re-
peat (BIR) motif, which to this date has been exclu-
sively found in apoptosis inhibitors of the IAP-related 
protein family. The BIR motifs of IAP proteins are in-
dispensable for their anti–cell death activity and are 
thought to function through protein–protein interac-
tion. This suggests that BRUCE may combine proper-
ties of IAP-like proteins and ubiquitin-conjugating en-
zymes and indicates that the family of IAP-like proteins 
is structurally and functionally more diverse than previ-
ously expected.
 
T
 
he
 
 central importance of selective proteolytic sys-
tems in regulating cellular key events has been rec-
ognized recently. Progression through the eukary-
otic cell cycle, for instance, is substantially regulated
through a timed and coordinated degradation of cyclins
and inhibitors of cyclin-dependent protein kinases (for re-
views see Hochstrasser, 1996; King et al., 1996). Similarly,
the shift from one transcriptional or developmental pro-
gram to another is often achieved through regulated de-
struction of regulatory proteins. Unlike several other post-
translational events (e.g., phosphorylation), proteolysis is
irreversible, and therefore proteolytic enzymes are usually
used for controlling unidirectional cellular pathways.
Selective degradation in eukaryotes primarily requires
the ubiquitin system that functions to mark proteins for
degradation by the multicatalytic protease, the protea-
some (for reviews see Ciechanover, 1994; Jentsch and
Schlenker, 1995; Hochstrasser, 1996; Varshavsky, 1997).
Proteins degraded by this pathway must first be recog-
nized as substrates by components of the ubiquitin system.
A cascade of reactions catalyzed by several classes of en-
zymes is required to form an isopeptide bond between the
COOH terminus of ubiquitin and the 
 
e
 
-amino group of a
lysine residue of an acceptor protein (for reviews see
Jentsch, 1992; Ciechanover, 1994; Hochstrasser, 1996; Var-
shavsky, 1997). Ubiquitin-activating (E1)
 
1
 
 enzyme hydro-
lyses ATP and forms a high-energy thioester between a
cysteine of its active site and the COOH terminus of ubiq-
uitin. Activated ubiquitin is then passed on to ubiquitin-
conjugating (E2) enzymes, which form thioester-linked
complexes with ubiquitin in a similar fashion. Finally,
ubiquitin is covalently attached to the substrate protein by
the E2 enzymes or, alternatively, by ubiquitin-protein li-
gases (E3), which may possess substrate-binding proper-
ties (Scheffner et al., 1995). Successive rounds of ubiquiti-
nation result in the formation of multiubiquitin chains
attached to proteolytic substrate proteins. Multiubiquiti-
nated proteins are then recognized and degraded by the
proteasome.
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Abbreviations used in this paper
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E1, ubiquitin-activating enzyme; IAP, inhibitor of apoptosis protein;
NAIP, neuronal apoptosis inhibitor protein; ORF, open reading frame;
UBC, ubiquitin-conjugating enzyme.
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E2 enzymes are thought to provide substrate specificity
to the proteolytic system and are encoded by large gene
families by apparently all eukaryotes. In the yeast 
 
Saccha-
romyces cerevisiae
 
, this family comprises 11 members
(ubiquitin-conjugating enzymes [UBC]), which can be dis-
tinguished by their intracellular localization and cellular
functions (Jentsch, 1992; Varshavsky, 1997). Known func-
tions of the yeast E2s include DNA repair, cell cycle pro-
gression, sporulation, peroxisome biogenesis, and heat and
heavy metal tolerance (Jentsch, 1992). Previously identi-
fied E2 enzymes are small proteins (16–35 kD) that bear a
conserved 
 
z
 
16-kD so-called UBC domain (Jentsch et al.,
1990). The active-site cysteine residue required for the for-
mation of a thioester-linked E2–ubiquitin complex is lo-
cated within this domain. Some E2s consist solely of the
UBC domain, whereas others possess short COOH-termi-
nal extensions. Among the known substrates are cyclins,
CDK inhibitors, transcription factors, subunits of trimeric
G proteins, and aberrant proteins (Hochstrasser, 1996;
Varshavsky, 1997). The majority of E2 enzymes are solu-
ble proteins of the cytosol and the nucleus, but in yeast,
three E2s are known to localize to intracellular mem-
branes. UBC10 is a peripheral membrane protein of per-
oxisomes and is required for the biogenesis of this or-
ganelle (Wiebel and Kunau, 1992). UBC6 and UBC7
localize to the ER and are integral and peripheral mem-
brane proteins, respectively. Both enzymes collaborate in
ER-associated degradation of short-lived and aberrant
proteins (Sommer and Jentsch, 1993; Biederer et al.,
1997). From higher eukaryotes, however, no membrane-
associated E2s have been reported previously.
Here we describe BRUCE (BIR repeat containing ubiq-
uitin-conjugating enzyme), a strikingly novel ubiquitin-
conjugating enzyme from mouse. BRUCE is a giant 528-kD
protein that, in contrast to previously identified ubiquitin-
conjugating enzymes, is associated with the Golgi com-
partment and the vesicular system. We show that the UBC
domain of BRUCE can be charged with ubiquitin in vitro,
indicating that the protein possesses ubiquitin-conjugating
activity. Remarkably, BRUCE also possesses a baculovi-
rus inhibitor of apoptosis repeat (BIR) motif, a hallmark
of apoptosis inhibitors of the IAP (inhibitor of apoptosis
protein) class. This emphasizes the structural diversity of
IAP-like proteins and suggests that its new member,
BRUCE, may function through its ubiquitin-conjugating
activity.
 
Materials and Methods
 
DNA Techniques
 
Standard DNA techniques were used (Ausubel et al., 1994).
 
 
 
Two degener-
ate primers (primers A and B from Matuschewski et al., 1996) corre-
sponding to conserved sequences of ubiquitin-conjugating enzymes were
used for amplification with genomic mouse DNA as a template. The ob-
tained PCR fragment was used for screening a mouse brain cDNA library
(CLONTECH Laboratories, Palo Alto, CA). One positive clone was iso-
lated and sequenced, and 5
 
9
 
 sequences were used as a probe in a subse-
quent screen. After 11 similar rounds of screening, 15 overlapping cDNA
clones encompassing a sequence of 15,475 bp with a single open reading
frame (ORF) of 14,535 bp were each subcloned via the EcoRI site into
pUC19 (Ausubel et al., 1994). All cDNA clones were sequenced at least
twice in both orientations using a sequenase kit (Amersham Corp., Ar-
lington Heights, IL). Northern blots of mouse multiple tissue and mouse
embryo (CLONTECH Laboratories) were probed with gene-specific 5
 
9
 
(bp 195–828) or 3
 
9
 
 sequences (bp 10865–15475), or with 
 
b
 
-actin cDNA for
loading control. Hybridization was carried out according to the manufac-
turer’s protocol.
 
Antibodies and Western Analysis
 
Two polypeptides corresponding to the NH
 
2
 
-terminal (amino acids 356–
493) and to the COOH-terminal (amino acids 4439–4845) part of BRUCE
fused to the His
 
6
 
-tag sequence were expressed and purified by the QIA
 
ex-
press
 
 System (Qiagen, Chatsworth, CA). After purification by SDS-PAGE,
rabbits were immunized with the protein, and two polyclonal antibodies,
“N” and “C” (corresponding to the NH
 
2
 
- and COOH-terminal fragments,
respectively), were obtained. Antibodies against synaptophysin, MAP2
(both from Boehringer Mannheim Corp., Indianapolis, IN), TGN38, and
TAU (kindly provided by G. Banting [University of Bristol, UK] and R.
Brandt [University of Heidelberg], respectively) are mouse monoclonals,
and anti-PDI antibodies are rabbit polyclonal (kindly provided by B.
Dobberstein [University of Heidelberg]). Dichlorotriazinyl-fluoresceine
(DTAF)- or lissamine rhodamine sulfonyl chloride (LRSC)-labeled and
peroxidase-conjugated goat anti–mouse and anti–rabbit antibodies were
purchased from Dianova (Hamburg, Germany). For Western blots, the
BRUCE protein of membrane fractions (see below) was separated by
4–14% gradient SDS-PAGE; all other proteins were separated by 12%
SDS-PAGE and transferred to polyvinyl difluoride membranes.
 
Cell Fractionations
 
For the experiment shown in Fig. 3 
 
B
 
, rat PC12 cells were metabolically la-
beled with [
 
35
 
S]methionine and cracked in homogenization buffer (10 mM
Hepes, pH 7.2, 0.25 M sucrose, 1 mM magnesium acetate, 1 mM EDTA,
1 mM PMSF, 10 
 
m
 
g/ml aprotinin, and 10 
 
m
 
g/ml leupeptin), and nuclei, or-
ganelles, and unbroken cells were pelleted by centrifugation at 1,000 
 
g
 
 for
10 min. The postnuclear supernatant was centrifuged at 100,000 
 
g
 
 for 60
min to obtain cytosolic and membrane fractions, and both fractions were
adjusted to the same volume (yielding fractions S and P, Fig. 3 
 
B
 
, lanes 
 
1
 
and 
 
2
 
). Two similarly prepared membrane fractions were further pro-
cessed by extensive washes with either 0.5 M NaCl or PBS by passing
through a 26-gauge needle, and the material was fractionated as above
into soluble (S) and pellet (P) fractions (Fig. 3 
 
B
 
, lanes 
 
3
 
 and 
 
4
 
, and 
 
5
 
 and
 
6
 
, respectively). BRUCE was detected in aliquots of these fractions by im-
munoprecipitation with antibodies C and N, and PDI and synaptophysin
control proteins were detected by Western blotting. Immunoprecipitation
of BRUCE with affinity-purified BRUCE-specific antibodies was carried
out in a buffer containing 0.3% NP-40, 0.5 mM EDTA, 0.5 mM PMSF, 5
 
m
 
g/ml aprotinin, and 5 
 
m
 
g/ml leupeptin for 1 h at 4
 
8
 
C. For the proteinase K
sensitivity experiment shown in Fig. 3 
 
C
 
, postnuclear supernatant without
protease inhibitors was incubated with or without 0.04 
 
m
 
g/ml proteinase K
for 15 min on ice. After addition of protease inhibitors (2 mM PMSF, 10
 
m
 
g/ml aprotinin, and 10 
 
m
 
g/ml leupeptin), membranes were pelleted by
centrifugation at 100,000 
 
g
 
 for 60 min, and BRUCE and PDI were de-
tected by Western blot analysis.
 
Confocal Microscopy
 
Rat neuroendocrine PC12 cells and primary rat hippocampal neurons
(kindly provided by A. Clement [University of Heidelberg]) were grown
on coverslips, washed once with PBS, fixed, and permeabilized with pre-
cooled methanol for 5 min at 
 
2
 
20˚C. After drying, cells were washed with
PBS and incubated with 10% goat serum for 20 min. Coverslips were incu-
bated with the respective antibodies, washed, and stained with secondary
antibodies (LRSC-labeled goat anti–mouse or DTAF-labeled goat anti–
rabbit antibodies [1:200]) as described (Bos et al., 1993). Confocal immuno-
fluorescence microscopy was performed using a Leica TCS
 
4D
 
 microscope
(Deerfield, IL) with a 63
 
3 
 
1.4 numerical aperture.
 
Thioester Assays
 
For thioester assays, ubiquitin was obtained by purifying a glutathione-
S-transferase–ubiquitin fusion (containing a thrombin-cleavage and a pro-
tein kinase A phosphorylation site; kindly provided by M. Scheffner [Ger-
man Cancer Center, Heidelberg, Germany]) from 
 
Escherichia coli 
 
cells
expressing pGEXUBI using a glutathione-Sepharose column. The fusion
protein was radiolabeled using protein kinase A and [
 
g
 
32
 
P]ATP and
cleaved with thrombin, and thrombin was heat-inactivated. Radiolabeled
SUMO-1 and NEDD8 were generated by a similar procedure (Schwarz et 
Hauser et al. 
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al., 1998). 
 
E. coli 
 
BL21(DE3) cells
 
 
 
transformed with plasmid pET3a
(Novagen, Madison, WI) expressing the COOH-terminal 406 amino acids
from BRUCE (
 
F
 
UBC) or cells transformed with plasmid pQE9 (Qiagen)
expressing an identical version NH
 
2
 
-terminally extended by additional six
histidine residues (
 
HF
 
UBC) were generated. Extracts from these cells
were incubated for 10 min at 25
 
8
 
C in the presence of a reticulocyte lysate
(as a source for ubiquitin-activating activity; Stratagene, La Jolla, CA)
and radiolabeled ubiquitin (or ubiquitin-like proteins) in a buffer contain-
ing 25 mM Tris, pH 7.5, 50 mM NaCl, 10 mM MgCl
 
2
 
, 10 mM ATP, and 0.1
mM DTT. Extracts from cells expressing UbcH7 ubiquitin-conjugating
enzyme were used as a positive control. The reaction products were incu-
bated with sample buffer under nonreducing or reducing conditions (10
min boiling in the presence of 100 mM DTT) followed by SDS-PAGE and
autoradiography.
 
Results
 
Identification of BRUCE and Expression Pattern
 
In the course of a homology-based screen for murine
genes encoding ubiquitin-conjugating enzymes (Matu-
schewski et al., 1996), we identified a DNA fragment that
hybridized to an exceptionally long mRNA. We obtained
15 overlapping complementary DNA (cDNA) clones after
12 rounds of screening, which identified a single large
ORF. The DNA sequence of this ORF (14,535 bp) pre-
dicts a giant protein with 4,845 amino acid residues (528 kD;
Fig. 1), which we termed BRUCE. Northern (RNA) anal-
ysis with probes corresponding to either NH
 
2
 
- or COOH-
terminal sequences of BRUCE detected an identical 
 
z
 
15-kb
mRNA species, confirming that the isolated cDNAs corre-
sponded to the same gene (Fig. 2). BRUCE is expressed in
most tissues of adult mice, yet most prominently in the
brain and the kidney. However, total mRNA levels vary
strongly during mouse embryogenesis, possibly indicating
that controlled levels of BRUCE are important during de-
velopment (Fig. 2). Similar mRNAs could be detected in
rat and man (not shown), indicating that BRUCE is ubiq-
uitously expressed in mammals.
 
Localization at Endomembranes
 
BRUCE is one of the largest proteins known to date, but
unlike most other giant proteins, it is nonrepetitive in
structure. The bulk of the protein exhibits no significant
sequence similarity to other known proteins and displays a
high percentage (
 
z
 
35%) of hydrophobic amino acid resi-
dues. We therefore speculated that the protein might be
membrane bound. Antibodies raised against NH
 
2
 
-terminal
and COOH-terminal domains of BRUCE, respectively,
identified an 
 
z
 
500-kD protein in cell extracts, and frac-
tionation studies indeed established a localization of the
protein chiefly in membrane fractions (Fig. 3, 
 
A 
 
and
 
 B
 
).
The protein was extractable by salt, indicating that
BRUCE is membrane associated but not embedded into
the lipid bilayer (Fig. 3 
 
B
 
). As indicated by proteinase K
sensitivity assays, the protein appears to localize to the cy-
Figure 1. Primary structure of BRUCE predicted from the cDNA sequence. (Sequence data are available from GenBank/EMBL/
DDBJ under accession number Y17267.) The NH2-terminally positioned single BIR repeat and the UBC domain close to the COOH
terminus are highlighted. The position of the presumed active-site cysteine residue required for thioester formation with ubiquitin is
marked within the UBC domain. The presumed initiator methionine residue was deducted from the position of the first ATG codon
found in the cDNA sequence. A schematic representation of the domain structure of BRUCE is shown at the bottom.
Figure 2. Levels of BRUCE transcripts. Northern blots of
oligo(dT)-purified mRNA from multiple tissues (left) and from
total mouse embryos (right; days 7–17 postconception; both blots
from CLONTECH Laboratories). Note that 39- (bp 10865–
15475), as well as 59-probes (bp 195–828) recognize the z15-kb
transcript of BRUCE. The transcript is particularly abundant in
brain and kidney, and levels vary during development. Actin
mRNA was used for loading control. (The lower bands represent
muscle-specific isoforms.) 
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tosolic face of the membrane (Fig. 3 
 
C
 
). Interestingly, con-
focal microscopy identified BRUCE in a punctated cyto-
solic distribution and in a Golgi-related compartment,
specifically the TGN, where the protein colocalized with
TGN38 (Bos et al., 1993; Humphrey et al., 1993), a TGN-
specific marker protein (Fig. 3 
 
D
 
). To refine the character-
ization of the intracellular distribution of BRUCE, we took
advantage of the highly polarized organization of neuronal
cells (Parton and Dotti, 1993). To this end, primary neu-
rons were prepared and stained for BRUCE with affinity-
purified BRUCE-specific antibodies. In these cells, be-
sides its localization in the TGN of the cell body, BRUCE
was also detectable in a dotted distribution in axons and
dendrites, indicating that the protein is additionally associ-
ated with more distal vesicular structures (Fig. 3 
 
D
 
).
 
BRUCE Is Related to Ubiquitin-conjugating Enzymes
 
The predicted primary sequence indicates that BRUCE
harbors a typical UBC domain close to the protein’s
COOH terminus (Fig. 1). UBC domains are hallmarks of
E2 enzymes of the ubiquitin-dependent proteolytic system
and related pathways (Jentsch et al., 1990). UBC domains
are specific for E2 enzymes and carry the active-site cys-
teine residue required for thioester formation (Jentsch et al.,
1990; and see introduction). It has been shown recently,
however, that UBC domains are also found in E2 en-
zymes, which mediate the conjugation of ubiquitin-like
proteins (Johnson and Blobel, 1997; Liakopoulos et al.,
1998; Schwarz et al., 1998). The UBC domain of BRUCE
is 
 
z
 
37% identical to those of other ubiquitin-conjugating
enzymes and harbors a putative active-site cysteine resi-
due at a conserved position (Fig. 4 
 
A
 
).
 
Ubiquitin-conjugating Activity of BRUCE
 
Because of the presence of a UBC domain, we speculated
that BRUCE possesses ubiquitin-conjugating activity. To
test this hypothesis, we asked whether the protein can be
charged in vitro with ubiquitin in a reaction depending on
ubiquitin-activating enzyme, E1. Because of the size of the
protein and the absence of a cDNA clone encompassing
the complete 14,535 bp of the BRUCE open reading
 
tion by Western blotting from the identical protein fractions.
These proteins used as controls were found in the pellet fraction.
A portion of lumenal PDI was also detectable in the cytosolic
fraction (
 
S
 
, 
 
first lane
 
), presumably because some microsomal ves-
icles were “inside-out” or disintegrated. (
 
C
 
) In contrast to lume-
nal PDI, BRUCE is sensitive to proteinase K treatment at mem-
branes in vitro, indicating that BRUCE faces to the cytosol. (
 
D
 
)
Confocal micrographs of rat PC12 cells and primary rat neurons
stained with antibodies (indirect immunofluorescence) specific
for BRUCE (
 
green
 
, antibodies C and N), and the marker pro-
teins (
 
red
 
) TGN38 (marker for TGN; Humphrey et al., 1993),
MAP2 (marker for dendrites), and TAU (marker for axons).
Note that BRUCE appears in a punctated cytosolic distribution
and is present in the TGN, axons, and dendrites. Colocalization
of BRUCE with marker proteins is shown by superimposition
(
 
yellow
 
). The BRUCE-specific antibodies used in these studies
(
 
A–D
 
) are affinity-purified, and the signals are specific since they
could be completely eliminated by competition with epitope-con-
taining protein fragments (not shown).
 
Figure 3.
 
The BRUCE protein is associated with endomem-
branes. (
 
A
 
) Western blot of membrane fractions from mouse
brain, mouse AtT20 (neuroendocrine), mouse N2a (neuroblas-
toma), and rat PC12 (neuroendocrine) cell lines probed with
BRUCE-specific antibodies (antibody C). (
 
B
 
) Immunoprecipita-
tion of in vivo–radiolabeled proteins with BRUCE-specific anti-
bodies (antibodies C and N) from cytosolic (
 
S
 
, supernatant) and
membrane (
 
P
 
, pellet) fractions (see Materials and Methods).
BRUCE is enriched in membrane fractions (see below) and can
be extracted by 0.5 M NaCl (compare lanes 
 
S
 
 and 
 
P
 
) or buffer
(
 
PBS
 
; compare lanes 
 
S
 
 and 
 
P
 
). Antibodies specific for the ER-lume-
nal protein disulfide isomerase (
 
PDI
 
) and synaptophysin, an inte-
gral membrane protein of synaptic vesicles, were used for detec- 
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frame, we expressed COOH-terminal fragments of
BRUCE in 
 
E. coli 
 
for enzyme assays. Two variants were
constructed, one corresponding to the COOH-terminal
406 amino acid residues of BRUCE containing its com-
plete UBC domain, and a similar version, extended by an
additional poly-histidine tag. Bacterial protein extracts ex-
pressing either of the two fragments were assayed in vitro
for thioester formation of the recombinant polypeptides
with radiolabeled ubiquitin in the presence of E1 activity
and ATP. Only in the presence of these bacterial extracts
(Fig. 4 
 
B
 
) were additional radiolabeled protein complexes
with sizes of 
 
z
 
55 and 
 
z
 
60 kD formed, consistent with the
sizes of adducts between ubiquitin and the shorter or
longer fragments of BRUCE’s UBC domain, respectively
(Fig. 4 
 
B
 
, 
 
2
 
DTT
 
, lanes 
 
4
 
 and 
 
5
 
). Complex formation de-
pended on ATP and the presence of E1 activity. The com-
plexes were sensitive to boiling under reducing conditions,
indicating that the protein fragments are indeed linked via
a thioester bond (Fig. 4 
 
B
 
, 
 
1
 
DTT
 
, lanes 
 
4
 
 and 
 
5
 
). This re-
action was specific for ubiquitin, as neither SUMO-1 nor
NEDD8, two mammalian ubiquitin-like proteins (Kumar
et al., 1992; Johnson and Hochstrasser, 1997), were able to
form adducts with the UBC domain of BRUCE under
similar conditions (data not shown).
 
BRUCE Is Related to IAP Apoptosis Inhibitors
 
Intriguingly, database searches identified in addition to
the UBC domain a single BIR repeat close to the NH2 ter-
minus of the BRUCE protein. BIR repeats are cysteine
rich, putative zinc-binding domains of about 70 amino acid
residues in length, which to this date have exclusively been
found in IAP-related apoptosis inhibitors. Members of the
family of IAP-related cell death inhibitors are character-
ized by the presence of up to three NH2-terminally posi-
tioned BIR repeats, followed by distinct COOH-terminal
sequences (Birnbaum et al., 1994; Hay et al., 1995; Rothe
et al., 1995; Roy et al., 1995; Ambrosini et al., 1997; Clem
and Duckett, 1997). Previously known members fall into
three classes, distinguished by their protein domain struc-
ture. The first class is represented by the anti-apoptotic
IAP proteins of baculovirus, insects, and mammals, which
are small proteins with up to three NH2-terminal BIR re-
peats, linked to a COOH-terminal RING finger (Birn-
baum et al., 1994; Hay et al., 1995; Rothe et al., 1995; Clem
and Duckett, 1997). The second class is defined by neu-
ronal apoptosis inhibitor protein (NAIP), a human 140-kD
protein with three NH2-terminal BIR repeats and a long
COOH-terminal tail that lacks a RING finger motif (Roy
et al., 1995; Liston et al., 1996). Survivin, a small human
cell death inhibitor, which essentially consists of a single
BIR motif, defines the third class (Ambrosini et al., 1997).
The BIR motif of BRUCE is z40% identical in se-
quence to those of other IAP relatives and bears all known
consensus elements of this domain, including a character-
istic cysteine/histidine motif, which is thought to function
Figure 4. BRUCE is a ubiquitin-conjugating enzyme. (A) Sequence com-
parison of the UBC domain of BRUCE (amino acids 4601–4671) with
those of other ubiquitin-conjugating enzymes (S. cerevisiae UBC1, -2, -3, -5,
-6, and -7; mouse UbcM2; human UbcH7 and -8; and Drosophila UbcD1).
Residues identical in at least four domains (majority) are shaded. The posi-
tion of the presumed active-site cysteine residue required for thioester for-
mation with ubiquitin is marked by an asterisk. (B) Thioester complex for-
mation between ubiquitin and fragments of BRUCE (FUBC, HFUBC)
consisting of the COOH-terminal 406 amino acid residues of BRUCE,
which include the complete UBC domain. Assay reactions contained ATP,
32P-labeled ubiquitin, reticulocyte lysate as a source for E1 activity, and
crude extracts from bacteria expressing FUBC, HFUBC, or UbcH7 (Nuber
et al., 1996; human ubiquitin-conjugating enzyme as positive control). Re-
actions were analyzed by SDS-PAGE under nonreducing (2DTT) or re-
ducing (1DTT) conditions (Nuber et al., 1996). Note that only in the pres-
ence of FUBC or HFUBC were additional radiolabeled complexes with sizes
of z55 and z60 kD formed (2DTT, lanes 4 and 5), consistent with the
sizes of adducts between ubiquitin and FUBC or HFUBC, respectively.
These complexes are thioester-linked since they disappear after boiling un-
der reducing conditions (1DTT, lanes 4 and 5). Control reactions contain-
ing labeled ubiquitin incubated with either bacterial extract (lane 1), reticu-
locyte lysate (lane 2), or reticulocyte lysate plus extracts of bacteria harboring the vector plasmid (lane 3) are shown. Complex
formation of ubiquitin with added UbcH7 (lane 6) or UbcH7 present in the reticulocyte lysate (lanes 2–5) is used as positive control.
Bands corresponding to free 32P-labeled ubiquitin and the respective thioester adducts are indicated.The Journal of Cell Biology, Volume 141, 1998 1420
in zinc binding (Fig. 5). The structure of BRUCE is un-
precedented, however, as the protein has a single BIR re-
peat (similar to survivin) plus an exceptionally long tail,
which exhibits no homology to the extensions of previ-
ously known IAP relatives, i.e., the tail of NAIP and the
RING fingers of the IAP proteins. BRUCE is the first ex-
ample of an IAP-like protein with a known enzymatic ac-
tivity. Interestingly, the BIR motifs of BRUCE and sur-
vivin are unique since they contain an insertion of three
amino acid residues (one of which is a proline residue) in
between the two conserved halves of the BIR motif, which
we term the FY (rich in phenylalanine and tyrosine resi-
dues) and the CH (rich in cysteine and histidine residues)
regions, respectively. In the mouse genome, the regions
encoding the FY and CH domains of BRUCE are sepa-
rated by an intron (Pyrowolakis, G., and S. Jentsch, un-
published results). This suggests that the complete BIR
motif has probably evolved by exon shuffling and that the
FY and CH may represent functionally distinct folding do-
mains separated by a linker sequence.
Discussion
Apoptotic cell death is a highly regulated process of multi-
cellular organisms through which superfluous or harmful
cells are eliminated (for review see White, 1996). During
this process, apoptotic cells go through sequential steps of
disintegration that include chromatin cleavage, organelle
breakdown, and the fragmentation of cellular material
into membrane-surrounded vesicles that are rapidly in-
gested by neighboring cells. Cell death can be triggered by
a variety of stimuli, but once initiated, apoptosis appears
to proceed through a common pathway. The basic cell
death machine comprises a family of related cysteine pro-
teases, termed caspases, which cleave proteins COOH-ter-
minal of aspartate residues (for review see Salvesen and
Dixit, 1997). Caspases are synthesized as inactive proen-
zymes that are activated by proteolytic cleavage. The pro-
cessing sites themselves match the consensus cleavage
specificity of caspases, and it is thus assumed that the apop-
totic suicide program is orchestrated through a cascade of
auto- and trans-cleavages of different caspases. Activated
caspases can cleave further targets, including components
of the cytoskeleton, nuclear lamins, poly(ADP-ribose)
polymerase, DNA-dependent protein kinase, and inhibitor
of caspase-activated DNase (Salvesen and Dixit, 1997;
Enari et al., 1998; Sakahira et al., 1998). The cleavage of
these downstream targets is thought to execute the final cell
death program with the characteristic morphological changes.
The cellular suicide program can be blocked by a variety
of proteins, and many of these factors are known to inter-
fere with caspase function. Bcl-2, a membrane protein of
primarily the outer membrane of mitochondria, appears to
inhibit apoptosis by blocking the efflux of cytochrome c
from mitochondria (White, 1996; Reed, 1997). This in turn
is thought to impede caspase-9 activation because matura-
tion from its inactive proenzyme form is stimulated by cy-
tochrome c in conjunction with the Apaf-1 protein (Li et al.,
1997). In contrast, direct inhibition of caspase function is
achieved by the cell death inhibitor p35 from baculovirus,
which seems to act through caspase binding (Clem et al.,
1991; Bump et al., 1995; Xue and Horvitz, 1995).
Another group of anti-apoptotic proteins is the IAP
family of apoptosis inhibitors (for review see Clem and
Duckett, 1997). Members of this protein family are distin-
guished by the presence of up to three BIR motifs. BIR
motifs are required, and often sufficient, for the anti-apop-
totic function of IAP-related proteins and are known to
act through protein–protein interactions (Clem and Duck-
ett, 1997). Several binding proteins have been found previ-
ously, which include TRAF signaling molecules (Rothe et al.,
1995) and the proteins Doom and Reaper from flies (Har-
vey et al., 1997; Vucic et al., 1997). Recent data indicated
that a principal anti-apoptotic function of BIR-containing
proteins may be their ability to bind and inhibit specific
caspases (Devereaux et al., 1997; Roy et al., 1997; Sesha-
giri and Miller, 1997).
In this paper we identify BRUCE, an unusual mem-
brane-associated protein from mouse that combines prop-
erties of IAP-like proteins with ubiquitin-conjugating en-
zymes. Although the cellular function of BRUCE is not
known at present, the intriguing modular design of the
protein with an NH2-terminal BIR repeat and an active
ubiquitin-conjugating enzyme domain at the protein’s
COOH terminus suggests a role in coupling anti-apoptosis
pathways to the ubiquitin/proteasome proteolytic machin-
ery. It seems attractive to speculate that BRUCE may be
regulated by specific BIR motif–binding proteins or, alter-
natively, may target these proteins (e.g., caspases) for deg-
radation. In contrast to a possibly reversible inhibition of
caspases by other IAP relatives, proteolytic inactivation of
apoptosis regulators would allow an irreversible shut-
down of specific cell death pathways.
BRUCE is structurally strikingly different from previ-
ously known E2 enzymes, which are small proteins (14–34
kD) that either consist of the UBC domain alone (class I)
or possess additional short COOH- (class II) or NH2-ter-
minal (class III) extensions (Jentsch et al., 1990; Matu-
Figure 5. Sequence comparison of the BIR motif of BRUCE (amino acids 261–333) with those from other IAP relatives. Residues iden-
tical in at least four motifs (majority) are shaded. Individual BIR repeats found in a single protein are numbered (I–III). The BIR motif
of BRUCE is z40% identical in sequence to those of other IAP relatives, with a conserved FY (left part) and CH region (right part; see
text).Hauser et al. Giant IAP-related Ubiquitin-conjugating Enzyme 1421
schewski et al., 1996). BRUCE, which bears a long NH2-
terminal and a short COOH-terminal extension, defines a
new class of E2 enzymes, termed class IV. Interestingly,
the overall domain structure of BRUCE resembles more a
class of E3 enzymes (ubiquitin ligases) of the ubiquitin sys-
tem that possess COOH-terminal, so-called HECT do-
mains involved in thioester formation with ubiquitin
(Huibregtse et al., 1995; Scheffner et al., 1995, Rosa et al.,
1996). These E3 enzymes typically bear within their NH2-
terminal domains binding sites for proteolytic substrates
and for cofactors that alter the enzyme’s substrate specific-
ity (Huibregtse et al., 1995; Scheffner et al., 1995). This
modular structure enables the enzyme to bind substrates
directly and to catalyze their ubiquitination via its COOH-
terminal catalytic domain. It is conceivable that BRUCE
may function analogously and that the BIR motif of
BRUCE constitutes either a binding site for a substrate or
a regulator.
BRUCE also differs from previously known E2 en-
zymes with respect to its intracellular localization.
BRUCE is the first example of a membrane-associated E2
enzyme from mammalian cells, and its localization at a
Golgi-related compartment and the vesicular system is un-
precedented for this enzyme class. Remarkably, only one
other enzyme of the ubiquitin system has been detected at
a Golgi-related compartment previously. This is p532, a
very large putative E3 ubiquitin ligase with a COOH-ter-
minal HECT domain and an expression pattern similar to
BRUCE (Rosa et al., 1996). This enzyme bears several
WD and RCC1 repeats, binds clathrin, and stimulates gua-
nine nucleotide exchange on ARF1 and Rab proteins,
which are important for membrane fusion and trafficking
(Rosa et al., 1996; Rosa and Barbacid, 1997). How this
function is mechanistically tied to the ubiquitin system is
not known at present, but it will be important to test
whether BRUCE as an E2 enzyme can charge this large
putative E3 enzyme with ubiquitin. If so, it seems attrac-
tive to speculate that their cooperative function is linked
to the membrane fusion events that occur during apopto-
sis. Further studies require the assembly of the complete
z15-kb cDNA of BRUCE into a single clone for gene
transfer studies, which are expected to answer if and how
BRUCE is involved in preventing apoptosis.
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